(Z)-2-ethylidenecyclopentanone | 39799-14-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (Z)-2-ethylidenecyclopentanone
• 英文别名: 2-ethylidenecyclopentanone；(2Z)-2-Ethylidenecyclopentan-1-one
• CAS: 39799-14-9
• 化学式: C₇H₁₀O
• 分子量: 110.156
• InChiKey: XUESHTLXMCHZSD-KXFIGUGUSA-N

物化性质

• 沸点：
  182.8±10.0 °C(Predicted)
• 密度：
  1.075±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (Z)-2-ethylidenecyclopentanone 、 (E)-2-ethylidenecyclopentanone 生成 2-乙基-环戊-2-烯酮
  参考文献：
  名称：

  SCHMIDT-RENNER, W.;ADLER, E.;KRAUS, W.;KUEBLER, R.;MATSCHINER, H.

  摘要：

  DOI：
• 作为产物：
  描述：

  5-三甲基甲硅烷基庚-5-烯酸 在 三氯化铝 、 草酰氯 作用下， 以 二氯甲烷 为溶剂， 反应 13.0h， 生成 (Z)-2-ethylidenecyclopentanone
  参考文献：
  名称：

  乙烯基硅烷的分子内酰化。一种新颖的合成四至六元碳环系统的通用方法及其区域化学特征

  摘要：

  描述了间-三甲基甲硅烷基-间链烯酰氯的分子内酰化（m ＝ 4和5），其根据底物结构提供预期的α-亚烷基环烯酮和/或意外的环烯酮。

  DOI：

  10.1016/s0040-4039(00)81530-0

文献信息

• Rhodium(I)-Catalyzed Intramolecular Hydroacylation of 4,6-Dienals: Novel Synthesis of Cycloheptenones
  作者：Yoshihiro Sato、Yoshihiro Oonishi、Miwako Mori

  DOI：10.1055/s-2007-983774

  日期：2007.7

  Rhodium(I)-catalyzed hydroacylation of 4,6-dienals was investigated. Hydroacylation of 4,6-dienals with a substituent at the C7 position produced cycloheptenone derivatives as the major products, while the cyclization of 4,6-dienals with no substituent at the terminus of the diene moiety preferentially gave cyclopentanone derivatives. The olefinic geometry of the diene moiety in 4,6-di-enals also affected

  研究了铑 (I) 催化的 4,6-二烯醛的加氢酰化。在 C7 位具有取代基的 4,6-二烯醛的氢化酰化产生环庚烯酮衍生物作为主要产物，而在二烯部分末端没有取代基的 4,6-二烯醛的环化优先产生环戊酮衍生物。4,6-二烯中二烯部分的烯烃几何形状也影响反应过程，底物与 C6 位 E-烯烃的环化产生环庚烯酮衍生物作为主要产物，而环戊酮衍生物由在 C6 位置具有 Z-烯烃的底物。
• Chiral diphosphorus compounds and transition metal complexes thereof
  申请人：Knochel Paul

  公开号：US20050288523A1

  公开（公告）日：2005-12-29

  The present invention relates to chiral diphosphorus compounds and transition metal complexes thereof, to a process for preparing chiral diphosphorus compounds and oxides thereof, and transition metal complexes comprising the chiral diphosphorus compounds. In a further aspect, the invention relates to the use of the chiral diphosphorus compounds or transition metal complexes thereof in asymmetric syntheses.

  本发明涉及手性二膦化合物及其过渡金属配合物，涉及制备手性二膦化合物及其氧化物的方法，以及包含手性二膦化合物的过渡金属配合物。此外，该发明还涉及在不对称合成中使用手性二膦化合物或其过渡金属配合物。
• SUBSTITUTED AMINOINDANES AND ANALOGS THEREOF, AND THE PHARMACEUTICAL USE THEREOF
  申请人：Rackelmann Nils

  公开号：US20110201590A1

  公开（公告）日：2011-08-18

  The invention relates to substituted aminoindanes and analogs thereof of formula (I) and the pharmaceutical use thereof. Medicaments which comprise compounds of this type are suitable for the prevention or treatment of diverse disorders such as, for example, of respiratory disorders, cystic fibrosis disorders, acute or chronic renal disorders or bowel disorders.

  该发明涉及公式（I）的替代氨基茚和类似物及其药用。包含这类化合物的药物适用于预防或治疗各种疾病，例如呼吸系统疾病、囊性纤维化疾病、急性或慢性肾脏疾病或肠道疾病。
• Process for producing 2-alkyl-2cyclopentenones
  申请人：TAKASAGO INTERNATIONAL CORPORATION

  公开号：US20030109755A1

  公开（公告）日：2003-06-12

  Industrially advantageous processes for producing a 2-alkyl-2-cyclopentenone in high yields starting from a 2-(1-hydroxyalkyl)cyclopentanone or a 2-alkylidenecyclopentanone, which are obtainable from a cyclopentanone and a carbonyl compound. A 2-(1-hydroxyalkyl)cyclopentanone represented by the following general formula (1): 1 (wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 each independently represents hydrogen atom, an alkyl group having 1 to 10 carbon atoms which may have one or more substituents or an aromatic group which may have one or more substituents, and each of (1) R 6 or R 7 with R 3 and (2) R 6 or R 7 with R 4 or R 5 may be together combined to form a ring which may have a double bond) is subjected to dehydrative isomerization in the presence of a bromine compound and/or an iodine compound.

  从环戊酮和羰基化合物获得的2-(1-羟基烷基)环戊酮或2-烷基亚烯环戊酮，是从高产率开始生产2-烷基-2-环戊酮的工业上有利的过程。在以下一般式（1）中表示的2-(1-羟基烷基)环戊酮中（其中R1、R2、R3、R4、R5、R6和R7分别独立地表示氢原子、具有1至10个碳原子的烷基基团，可能具有一个或多个取代基或可能具有一个或多个取代基的芳香基团，且(1) R6或R7与R3和(2) R6或R7与R4或R5中的每一个可能结合在一起形成可能具有双键的环)在溴化合物和/或碘化合物的存在下进行脱水异构化。
• Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
  申请人：Bowen J. Phillip

  公开号：US20090018167A1

  公开（公告）日：2009-01-15

  The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize, exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also relates to the use of chalcone and its analogs as antitumor/anticancer agents and to treat a number of conditions or disease states in which angiogenesis is a factor, including angiogenic skin diseases such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, lymphangiogenesis, among numerous others, as well as chronic inflammatory disease such as arthritis.

  本发明涉及用作血管生成抑制剂的查尔酮和查尔酮衍生物和类似物。这些廉价合成的化合物表现出意外的良好的血管生成抑制活性。本发明还涉及将查尔酮及其类似物用作抗肿瘤/抗癌剂，并用于治疗许多与血管生成有关的疾病或病态，包括血管生成性皮肤疾病，如银屑病、痤疮、酒渣鼻、疣、湿疹、血管瘤、淋巴管生成等，以及慢性炎症性疾病，如关节炎。